Evaluation of Concomitant Imaging Dose in 4D-CBCT Guided Thoracic Radiotherapy
Technology in Cancer Research & Treatment · 2025
DOI: 10.1177/15330338251366729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Wu Jianan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Ac…. Hauptthemen laut MEDLINE: Radiotherapy, Image-Guided, Four-Dimensional Computed Tomography, Cone-Beam Computed Tomography, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shenzhen High-level Hospital Construction Fund, Sanming Project of Medicine in Shenzen Municipality, Hospital Research Project.
Abstract (Originalsprache)
Introduction
This retrospective study evaluated the imaging dose of 4D-CBCT in patients treated with thoracic radiotherapy.
Methods
A geometric model of a 4D-CBCT system was built for Monte Carlo (MC) calculations. Percentage depth dose (PDD) and profiles of the system were measured and compared with MC calculations to verify the model. Eight lung cancer patients were retrospectively selected for 4D-CBCT imaging dose assessment. For each patient, the imaging dose was calculated using the CBCT log file, simulating CT and the MC model. Organ at risk (OAR) dose parameters from the imaging dose were calculated, and the effect of the imaging dose on OAR dose parameters when the imaging dose was added to the treatment dose was analyzed.
Results
Deviations between MC calculations and measurements for PDD and profiles were within 1.1% and 5%, respectively. For a pre-treatment 4D-CBCT scan, the mean lung and heart doses were 9.5 ± 1.4 mGy (mean value ± standard deviation, hereafter the same) and 9.7 ± 1.4 mGy, and the maximum spinal cord, esophagus and ribs doses were 17.6 ± 4.2 mGy, 17.1 ± 3.3 mGy and 37.8 ± 5.3 mGy, respectively. For an in-treatment 4D-CBCT scan, the dose parameters were 5.6 ± 1.8 mGy, 5.6 ± 1.5 mGy, 10.3 ± 3.5 mGy, 10.3 ± 4.3 mGy and 22.4 ± 5.3 mGy, respectively. The OAR dose parameters for in-treatment 4D-CBCT scans showed a relatively strong linear relationship with beam MU and number of frames. For patients receiving 5-fraction treatments and one pre-treatment and one in-treatment 4D-CBCT for each fraction, the increases in lung V20, lung V5, mean lung and heart doses, maximum spinal cord, esophagus and ribs doses were 0.04 ± 0.03%, 0.29 ± 0.23%, 76.3 ± 14.4 mGy, 76.5 ± 12.0 mGy, 76.3 ± 20.2 mGy, 70.5 ± 13.1 mGy and 101.2 ± 20.5 mGy, respectively. The increase in OAR dose parameters was proportional to the number of fractions.
Conclusion
The imaging dose of pre-treatment and in-treatment 4D-CBCT was calculated using a validated MC model. For 5-fraction treatments, the imaging dose will likely have minimal clinical impact on OAR dose parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen,…
- Department of Radiation Oncology, Guangzhou Concord Cancer Hospital, Guangzhou, People's Republic of China.
Förderung
- Shenzhen High-level Hospital Construction Fund
- Sanming Project of Medicine in Shenzen Municipality
- Hospital Research Project
- National Natural Science Foundation of China
- Shenzhen Key Medical Discipline Construction Fund
- Shenzhen Science and Technology Program
Zitieren
APA
Jianan, W., Yong, S., Zhangmin, L., Ying, L., Man, Z., Yuchao, H., & Yajun, J. (2025). Evaluation of Concomitant Imaging Dose in 4D-CBCT Guided Thoracic Radiotherapy. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251366729
Vancouver
Jianan W, Yong S, Zhangmin L, Ying L, Man Z, Yuchao H, et al. Evaluation of Concomitant Imaging Dose in 4D-CBCT Guided Thoracic Radiotherapy. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251366729
BibTeX
@article{Jianan2025,
author = {Jianan, Wu and Yong, Sang and Zhangmin, Li and Ying, Liang and Man, Zhao and Yuchao, Hu and Yajun, Jia},
title = {Evaluation of Concomitant Imaging Dose in 4D-CBCT Guided Thoracic Radiotherapy},
journal = {Technology in Cancer Research & Treatment},
year = {2025},
doi = {10.1177/15330338251366729}
}
EUVIMED